BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1138180)

  • 1. Carcinoma of the urinary bladder in patients receiving cyclophosphamide.
    Wall RL; Clausen KP
    N Engl J Med; 1975 Aug; 293(6):271-3. PubMed ID: 1138180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.
    Pedersen-Bjergaard J; Ersbøll J; Hansen VL; Sørensen BL; Christoffersen K; Hou-Jensen K; Nissen NI; Knudsen JB; Hansen MM
    N Engl J Med; 1988 Apr; 318(16):1028-32. PubMed ID: 3352696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer of the bladder after cystitis due to cyclophosphamide. Apropos of a case].
    Dore B; Grange P; Aubert J
    J Urol (Paris); 1989; 95(7):427-31. PubMed ID: 2687398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
    Stillwell TJ; Benson RC
    Cancer; 1988 Feb; 61(3):451-7. PubMed ID: 3338015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal hemorrhagic cystitis induced by pelvic irradiation and cyclophosphamide therapy. Case reports and review.
    Price WE; Keldahl LR
    Minn Med; 1990 May; 73(5):39-41, 44. PubMed ID: 2113164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
    Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
    Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of mucosal change in the urinary bladder in nonhematuric patients with long-term exposure and/or accumulating high-dose cyclophosphamide. Possible significance of follow-up cystoscopy on preventing development of cyclophosphamide-induced hemorrhagic cystitis.
    Kimura M; Tomita Y; Morishita H; Takahashi K
    Urol Int; 1998 Oct; 61(1):8-11. PubMed ID: 9792975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years.
    Volm T; Pfaff P; Gnann R; Kreienberg R
    Gynecol Oncol; 2001 Jul; 82(1):197-9. PubMed ID: 11426986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current topics in the pathology of bladder cancer.
    Murphy WM
    Pathol Annu; 1983; 18 Pt 1():1-25. PubMed ID: 6410347
    [No Abstract]   [Full Text] [Related]  

  • 11. Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: report of two cases.
    Tanguay C; Harvey I; Houde M; Srigley JR; Têtu B
    Mod Pathol; 2003 May; 16(5):512-4. PubMed ID: 12748258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.
    Talar-Williams C; Hijazi YM; Walther MM; Linehan WM; Hallahan CW; Lubensky I; Kerr GS; Hoffman GS; Fauci AS; Sneller MC
    Ann Intern Med; 1996 Mar; 124(5):477-84. PubMed ID: 8602705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous cyclophosphamide in patients with chronic systemic inflammatory diseases: morbidity and mortality.
    Gøransson LG; Brodin C; Ogreid P; Janssen EA; Romundstad PR; Vatten L; Wildhagen K; Kjellevold K; Omdal R
    Scand J Rheumatol; 2008; 37(2):130-4. PubMed ID: 18415771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endoxan hemorrhage from the bladder. Sterile hemorrhagic cystitis caused by cyclophosphamide].
    Pauwels RP; Moonen WA; Janknegt RA
    Ned Tijdschr Geneeskd; 1969 Oct; 113(43):1883-8. PubMed ID: 5345768
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urothelial carcinoma of the bladder following cyclophosphamide therapy].
    Blume B; Rabe F; Theuring F
    Z Urol Nephrol; 1984 Jan; 77(1):7-9. PubMed ID: 6702330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma of the bladder complicating cyclophosphamide therapy.
    Ansell ID; Castro JE
    Br J Urol; 1975 Aug; 47(4):413-8. PubMed ID: 1180990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis.
    Plotz PH; Klippel JH; Decker JL; Grauman D; Wolff B; Brown BC; Rutt G
    Ann Intern Med; 1979 Aug; 91(2):221-3. PubMed ID: 464465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A; Korkmaz A; Oter S; Coskun O
    Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.